Showing results (1951-1960 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|January 7, 1997
An economic evaluation of the use of granulocyte colony-stimulating factor after bone marrow transplantation in childrenN Duncan, M Hewetson, A Atra, et al.Pharmacoeconomics|January 7, 1997
Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasiaG L Plosker, K L GoaPharmacoeconomics|April 7, 1997
Sumatriptan. A pharmacoeconomic review of its use in migraineA J Coukell, H M LambPharmacoeconomics|May 7, 1997
Some aspects of the cost of schizophrenia in FranceF Rouillon, M Toumi, G Y Dansette, et al.Pharmacoeconomics|June 6, 1997
Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infectionJ V Chancellor, A M Hill, C A Sabin, et al.Pharmacoeconomics|June 6, 1997
Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in ItalyL Garattini, M Brunetti, F Salvioni, et al.Pharmacoeconomics|July 6, 1997
Cost-related information to be provided by computerised drug-prescription systems to promote cost-effective prescribingC Milstein, A VenotPharmacoeconomics|July 6, 1997
The cost effectiveness of pneumococcal vaccination strategiesC B Gable, M Botteman, G Savage, et al.Pharmacoeconomics|July 6, 1997
Economic impact of digoxin toxicityA J Gandhi, P H Vlasses, D J Morton, et al.Pageof 336